Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 41.0
(-5.86%)
TWD 41.0
(-5.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.15 Billion TWD | 22.75% |
| 2022 | -1.5 Billion TWD | -206.47% |
| 2021 | 1.41 Billion TWD | 304.18% |
| 2020 | -690.69 Million TWD | -8.46% |
| 2019 | -636.84 Million TWD | -33.7% |
| 2018 | -476.34 Million TWD | -39.98% |
| 2017 | -340.29 Million TWD | -62.36% |
| 2016 | -209.58 Million TWD | -15.33% |
| 2015 | -181.73 Million TWD | -72.41% |
| 2014 | -105.4 Million TWD | -37.25% |
| 2013 | -76.8 Million TWD | -249.1% |
| 2012 | -22 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 13.55 Million TWD | 118.47% |
| 2024 Q1 | -73.41 Million TWD | 87.39% |
| 2024 Q3 | 1.5 Million TWD | -88.88% |
| 2023 Q4 | -582.13 Million TWD | -1018.82% |
| 2023 Q1 | -212.16 Million TWD | 70.8% |
| 2023 Q3 | -52.03 Million TWD | 83.4% |
| 2023 Q2 | -313.5 Million TWD | -47.77% |
| 2023 FY | -1.15 Billion TWD | 22.75% |
| 2022 Q4 | -726.57 Million TWD | -128.02% |
| 2022 Q2 | -314.05 Million TWD | -120.87% |
| 2022 Q1 | -142.18 Million TWD | -113.34% |
| 2022 FY | -1.5 Billion TWD | -206.47% |
| 2022 Q3 | -318.64 Million TWD | -1.46% |
| 2021 Q2 | -178.76 Million TWD | -13.94% |
| 2021 Q4 | 1.06 Billion TWD | 56.67% |
| 2021 Q1 | -156.9 Million TWD | 16.09% |
| 2021 FY | 1.41 Billion TWD | 304.18% |
| 2021 Q3 | 680.2 Million TWD | 480.5% |
| 2020 Q3 | -183.02 Million TWD | -5.93% |
| 2020 FY | -690.69 Million TWD | -8.46% |
| 2020 Q2 | -172.78 Million TWD | -31.41% |
| 2020 Q1 | -131.48 Million TWD | 31.0% |
| 2020 Q4 | -186.98 Million TWD | -2.17% |
| 2019 Q3 | -126.18 Million TWD | 22.28% |
| 2019 FY | -636.84 Million TWD | -33.7% |
| 2019 Q4 | -190.56 Million TWD | -51.02% |
| 2019 Q2 | -162.36 Million TWD | -17.15% |
| 2019 Q1 | -138.6 Million TWD | 15.19% |
| 2018 Q4 | -163.42 Million TWD | -75.94% |
| 2018 FY | -476.34 Million TWD | -39.98% |
| 2018 Q2 | -130.07 Million TWD | -44.6% |
| 2018 Q1 | -89.95 Million TWD | 19.23% |
| 2018 Q3 | -92.88 Million TWD | 28.59% |
| 2017 FY | -340.29 Million TWD | -62.36% |
| 2017 Q4 | -111.37 Million TWD | -40.62% |
| 2017 Q2 | -80.58 Million TWD | -16.58% |
| 2017 Q3 | -79.2 Million TWD | 1.72% |
| 2017 Q1 | -69.12 Million TWD | 23.87% |
| 2016 Q4 | -90.79 Million TWD | -187.95% |
| 2016 Q3 | -31.53 Million TWD | 27.72% |
| 2016 Q1 | -43.62 Million TWD | -1.85% |
| 2016 Q2 | -43.62 Million TWD | 0.0% |
| 2016 FY | -209.58 Million TWD | -15.33% |
| 2015 Q3 | -42.83 Million TWD | 10.82% |
| 2015 Q1 | -48.03 Million TWD | -77.48% |
| 2015 Q2 | -48.03 Million TWD | 0.0% |
| 2015 FY | -181.73 Million TWD | -72.41% |
| 2015 Q4 | -42.83 Million TWD | 0.0% |
| 2014 FY | -105.4 Million TWD | -37.25% |
| 2014 Q4 | -27.06 Million TWD | 0.0% |
| 2014 Q3 | -27.06 Million TWD | -5.54% |
| 2014 Q2 | -25.64 Million TWD | 0.0% |
| 2014 Q1 | -25.64 Million TWD | 0.0% |
| 2013 FY | -76.8 Million TWD | -249.1% |
| 2012 FY | -22 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 562.062% |
| Level Biotechnology Inc. | 62.9 Million TWD | 1943.788% |
| Sagittarius Life Science Corp | -55.03 Million TWD | -2007.297% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | -1694.16% |
| TaiMed Biologics Inc. | -194.81 Million TWD | -495.367% |
| GlycoNex Incorporation | -178.36 Million TWD | -550.27% |
| VBI | -6.6 Million TWD | -17470.595% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | -597.561% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -10757.845% |
| Visgeneer Inc. | -19.58 Million TWD | -5820.848% |
| Mycenax Biotech Inc. | -682.84 Million TWD | -69.853% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 285.364% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 1701.982% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -19080.337% |
| Enimmune corporation | -223.74 Million TWD | -418.378% |
| TaiRx, Inc. | -212.29 Million TWD | -446.339% |
| CHO Pharma, Inc. | -306.08 Million TWD | -278.923% |
| EirGenix Inc. | -915.2 Million TWD | -26.729% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 2431.655% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | -1731.704% |
| Lin BioScience, Inc. | -687.19 Million TWD | -68.779% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | -641.938% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 5188.781% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | -1482.636% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -2349.338% |
| RBC Bioscience Corporation | 6.43 Million TWD | 18137.869% |
| BiOptic Inc. | 37.74 Million TWD | 3172.655% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | -68.575% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -3020.772% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | -1784.685% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 522.024% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -2139.842% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -2938.444% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | -590.107% |
| Neith Corporation | -40.03 Million TWD | -2797.197% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | -1159.185% |
| NaviFUS Corp. | -65.72 Million TWD | -1664.571% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | -1216.663% |
| Sinew Pharma Inc. | -170.92 Million TWD | -578.58% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | -1601.661% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 987.647% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | -387.242% |
| AP Biosciences Inc | -339.29 Million TWD | -241.837% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | -106.635% |
| 3D Global Biotech Inc. | -57.95 Million TWD | -1901.406% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 13816.119% |
| Intech Biopharm Corporation | -337.98 Million TWD | -243.16% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 11.656% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -2147.176% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | -579.526% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 315.024% |
| TCI GENE Inc. | 11.67 Million TWD | 10036.049% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | -809.332% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | -291.431% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | -433.228% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 11560.82% |
| PharmaEngine, Inc. | 274.65 Million TWD | 522.296% |
| Savior Lifetec Corporation | 30.03 Million TWD | 3962.254% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 948.26% |
| OBI Pharma, Inc. | -1.04 Billion TWD | -10.833% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | -825.307% |
| Acepodia, Inc. | -817.31 Million TWD | -41.907% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | -137.45% |